Susan Hasty, Publisher
Table of Contents . . . October 4th, 2000
Non-Subscriber - Summaries OnlyRelated Areas: Other Issues in Immunotherapy Weekly | Other Publications
HIV Immunotherapy - Interleukin-2 Plus Antiretroviral Therapy Increases CD4+ Levels
HIV Vaccines - Immunotherapy Evaluated in SIV Infected Rhesus Macaque Model
Allergy Medicine - Birch-Pollen Immunotherapy Does Not Change Cytokine Profile
Allergy Medicine - Effectiveness of Allergoids Dependent on Type of Antigen-Presenting Cells Stimulated
Allergy Medicine - Immunotherapy Improves Allergic Conjunctivitis
Anaphylaxis - DNA-Based Vaccines Reduce Risk of Hypersensitivity in Mice
Immunoregulation - Cis-Urocanic Acid Mediates UVB-Induced Suppression of Immunity in Rats
Ovarian Cancer - Results from Chemo-Immunotherapy in Murine Model are Dismal
Vector Development - Receptor-Specific Retroviruses are More Efficient for Cancer Immunotherapy
Environment - Chemical Found in Computer Can Cause Allergies and Sickness
HIV Immunotherapy - Early Antiviral Treatment Primes Immune System to Suppress Viral Levels Without Drugs
HIV Vaccines - Remune Addition Announced to Treat Primary HIV Infection
HIV Vaccines - Scientists Reveal Possible New Target
Interferon Therapy - Collaboration Will Develop PEGylated Natural Alpha Interferon to Treat Hepatitis C
Interferon Therapy - Pretreatment with Corticosteroids and Thymic Extract Studied in HBV Patients
Interferon Therapy - Twice-Daily Interferon Regimen Clears Viral RNA But Increases Toxic Effects
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.